Lantheus

Witness the Future of Echo: The 2026 Shark Tank Innovation Competition

Get a front-row seat to the evolution of cardiovascular ultrasound! The ASE Shark Tank Innovation Competition returns for its second year, featuring a vetted group of entrepreneurs pitching their cutting-edge innovative solutions to a panel of venture capital and cardiovascular ultrasound experts.

Why You Should Attend: 

  • Direct Access to frontier technology: Be the first to see the diagnostic solutions that are coming to market. 
  • Observe expert analysis: Listen in as our panel of "Sharks grill the applicants on innovation and business sustainability. 
  • Find the "Next Big Thing": Last year, Echo IQ won the top prize for their proprietary AI platform, EchoSolv. Who will the judges crown the champion this year? 

Event Details 

  • When: Friday, June 26, 2026 | 1:45 – 2:45 PM MT 
  • Where: Gaylord Rockies Resort, Aurora, Colorado (During ASE 2026 Scientific Sessions) 

Meet the Competitors 

  • Bloom Standard Inc.’s EVA RAPIDscan system standardizes image acquisition for rapid screening, triage and echo spot checks.
  • CircuCare’s Cynova is an AI-powered wearable robotic ultrasound platform designed for autonomous and continuous cardiac imaging.
  • eMyosound Inc.’s Vocelo™ uses ultrafast ultrasound and 3D shear wave elastography to quantify myocardial stiffness throughout the cardiac cycle.
  • iCardio.ai’s EchoMeasure automates echocardiographic measurements to reduce sonographer workload and improve standardization.

Come for the excitement, stay for the innovation! Also, don't miss the Fireside Chat with Dr. Partho Sengupta, Dr. Pamela Douglas, Dr. Theodore Abraham, and Dr. Steven Lester while the judges deliberate the Shark Tank winner!

ASE-4703_Shark Tank at ASE 2026 banner_1024x302_r2

2025 Shark Tank Competitors & Winner

Held during ASE’s 2025 Scientific Sessions in Nashville, Tenn., the inaugural Shark Tank Innovation Competition showcased emerging technologies in cardiovascular ultrasound aimed at addressing real-world clinical challenges. The competition featured three finalists: Microvascular Therapeutics, Sonus Microsystems, and Echo IQ. 

The winning prize went to Echo IQ, the innovators behind EchoSolv, an FDA-cleared clinical decision support tool that transforms the detection of structural heart disease. 

Powered by Echo IQ’s proprietary AI platform, EchoSolv analyzes echocardiographic data to identify at-risk patients with 98.5% accuracy in under 3 seconds. Although the audience preferred Microvascular Therapeutics (MVT) and voted them as their favorite, the Shark Tank judges selected Echo IQ for its promising combination of a breakthrough technology with a sustainable business model.